|
2025
|
Invention
|
Engineered virus.
The present invention relates to oncolytic virus comprising: (i) a GM-CSF-enco... |
|
|
Invention
|
An oncolytic herpes simplex virus (hsv) and an anti-pd-1 antibody for use in treating braf mutant... |
|
2024
|
Invention
|
Altered virus.
The present invention relates to an oncolytic virus encoding a CTLA-4 inhibitor, ... |
|
|
Invention
|
Oncolytic virus strain. The present invention relates to an oncolytic virus which is, or is deriv... |
|
2023
|
P/S
|
Pharmaceutical drug research and development services; research and development of vaccines and m... |
|
|
P/S
|
Pharmaceutical preparations; viruses; viruses for the treatment of disease; viruses for the treat... |
|
|
P/S
|
Viruses for the treatment of cancer; pharmaceuticals for the treatment of cancer; Biological prep... |
|
|
Invention
|
Engineered virus. The present invention relates to oncolytic virus comprising: (i) a GM-CSF-encod... |
|
2022
|
Invention
|
Modified oncolytic virus. The present invention relates to an oncolytic virus comprising: (i) a f... |
|
2019
|
Invention
|
Treatment using oncolytic virus.
An oncolytic virus for use in a method of treating or preventin... |
|
|
Invention
|
Treatment using oncolytic virus. in vitroin vitroin vitro than one or more of the other clinical ... |
|
|
Invention
|
Treatment using oncolytic virus. An oncolytic virus for use in a method of treating or preventing... |
|
2018
|
Invention
|
Altered virus. The present invention relates to an oncolytic virus encoding a CTLA-4 inhibitor, s... |
|
|
Invention
|
Modified herpes simplex virus expressing ctla-4 inhibitor. The present invention relates to an on... |
|
2017
|
P/S
|
Viruses; viruses for the treatment of disease; viruses for the treatment of cancer; viruses for i... |
|
|
P/S
|
[ Pharmaceutical drug research and development services; research and development of vaccines and... |
|
|
Invention
|
Use of an oncolytic virus for the treatment of cancer. The present invention provides a method of... |
|
|
Invention
|
Oncolytic herpes simplex virus type 1 strain. The present invention relates to improved herpes si... |
|
|
Invention
|
Oncolytic virus comprising a fusogenic protein-encoding gene and immune stimulatory protein-encod... |
|
|
Invention
|
Oncolytic virus comprising a gm-csf-encoding gene and an immune co-stimulatory pathway activating... |
|
|
Invention
|
Modified oncolytic viurs. The present invention relates to an oncolytic virus comprising: (i) a f... |
